Improved paclitaxel-based antitumor formulation

Details for Australian Patent Application No. 2003200926 (hide)

International Classifications

Event Publications

20 March 2003 Complete Application Filed

Priority application(s): MI2002A000680 29.03.02 IT

16 October 2003 Application Open to Public Inspection

Published as AU-A-2003200926

24 May 2007 Assignment before Grant

ACS DOBFAR S.p.A. The application has been assigned to Abraxis BioSciences, Inc.

14 June 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.